Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Stability of the novel blood‐based biomarkers under pre‐analytical sample handling conditions: Results of the SABB‐GBSC working group.

Autor: Verberk, Inge M.W., Misdorp, Els O., Koelewijn, Jannet, Ball, Andrew J., Blennow, Kaj, Dage, Jeffrey L., Fandos, Noelia, Hansson, Oskar, Hirtz, Christophe, Janelidze, Shorena, Lee, Ryan, Rissman, Robert A., Shan, Dandan, Shaw, Leslie M., Yarasheski, Kevin E., Zetterberg, Henrik, Edelmayer, Rebecca M., Teunissen, Charlotte E.

Publikováno v: Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Dec2021 Supplement S5, Vol. 17, p1-6, 6p

Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group.

Autor: Verberk IMW; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Misdorp EO; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Koelewijn J; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Ball AJ; Quanterix Corporation, Billerica, Massachusetts, USA., Blennow K; Institute of Neuroscience and Physiology, The Salhgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden., Dage JL; Eli Lilly and Company, Indianapolis, Indiana, USA., Fandos N; Araclon Biotech, Zaragoza, Spain., Hansson O; Clinical Memory Research Unit, Lund University, Lund, Sweden., Hirtz C; IRMB-LBPC/PPC, INM, Univ Montpellier, CHU Montpellier, INSERM CNRS, Montpellier, France., Janelidze S; Clinical Memory Research Unit, Lund University, Lund, Sweden., Kang S; PeopleBio, Seongnam, South Korea., Kirmess K; C2N Diagnostics, St. Louis, Missouri, USA., Kindermans J; IRMB-LBPC/PPC, INM, Univ Montpellier, CHU Montpellier, INSERM CNRS, Montpellier, France., Lee R; PeopleBio, Seongnam, South Korea., Meyer MR; C2N Diagnostics, St. Louis, Missouri, USA., Shan D; Quanterix Corporation, Billerica, Massachusetts, USA., Shaw LM; Department of Pathology & Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Waligorska T; Department of Pathology & Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., West T; C2N Diagnostics, St. Louis, Missouri, USA., Zetterberg H; Institute of Neuroscience and Physiology, The Salhgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; UK Dementia Research Institute at UCL, London, UK.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Edelmayer RM; Alzheimer's Association, Chicago, Illinois, USA., Teunissen CE; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.

Publikováno v: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2022 Aug; Vol. 18 (8), pp. 1484-1497. Date of Electronic Publication: 2021 Nov 29.